期刊文献+

人源肝癌HepG2细胞胰岛素抵抗和逆转模型中FoxO1 mRNA和蛋白表达水平及其意义 被引量:1

Insulin resistance of human hepatoma HepG2 cells and expression levels of FoxO1 mRNA and protein in reversal model and their significances
下载PDF
导出
摘要 目的:探讨人源肝癌HepG2细胞胰岛素抵抗(IR)模型(HepG2/IR)和逆转模型(HepG2/IRPH)中叉头状转录因子O1(FoxO1)的mRNA和蛋白表达水平,阐明该基因参与IR的作用机制。方法:选择人源肝癌HepG2细胞,采用终浓度1×10^(-10)、1×10^(-9)、1×10^(-8)、1×10^(-7)、1×10^(-6)和1×10^(-5) mol·L^(-1)胰岛素诱导24、48和72h,对照组细胞不加胰岛素,用葡萄糖氧化酶法检测上清液中葡萄糖水平,计算各组细胞的葡萄糖消耗量,以确定IR模型建立的最佳诱导条件;采用终浓度为0.156、0.313、0.625、1.250、2.500、5.000、10.000、20.000mmol·L^(-1)盐酸吡咯列酮(PH)诱导HepG2建立逆转抵抗模型,同时设立对照组,MTT法检测细胞增殖活性,确定PH的最佳逆转浓度;利用Real-time PCR法和Western blotting法检测各组细胞FoxO1mRNA和蛋白表达水平。结果:1×10-7 mol·L^(-1)胰岛素作用36h,葡萄糖消耗量减少45.84%,发生明显的IR,与对照组比较差异有统计学意义(P<0.05)。与对照组比较,1.25mmol·L^(-1)PH逆转抵抗24h,细胞增殖活性无明显变化(P>0.05)。人源肝癌HepG2细胞发生IR时,与对照组比较,FoxO1mRNA和蛋白的表达水平均明显升高(P<0.01);IR模型逆转后,与对照组比较,FoxO1mRNA和蛋白表达水平差异无统计学意义(P>0.05)。结论:人源肝癌HepG2细胞IR与FoxO1mRNA的表达有关联性,FoxO1mRNA表达水平检测有可能作为胰岛素增敏剂的药效评估指标,降低FoxO1mRNA表达水平可作为2型糖尿病治疗的新靶点。 Objective: To study the expression levels of forkhead transcription factor (FoxO1) mRNA and protein in the insulin resistance (IR) HepG2 cells model (HepG2/IR) and IR reversal HepG2 cells model (HepG2/ IR-PH), and to explore its mechanism in IR. Methods: The HepG2/IR was induced with different doses of insulin (1×10^-l0, 1×10^-9, 1×10^-8, 1×10^-7, 1×10^-6 and 1×10^-5 mol · L^-1) for different time (24, 36 and 48 h) in the HepG2 cells. The cells in control group were not treated with insulin. The glucose levels in supernant were determined by glucose oxidase method, and the glucose consumption in HepG2 in various groups were calculated to confirm the optimum induction conditions of HepG2/IR. The HepG2/IR-PH was induced with different doses of pioglitazone hydrochloride (PH) (0. 156, 0. 313, 0. 625, 1. 250, 2. 500, 5. 000, 10. 000 and 20. 000 mmol ~ L-1) in the HepG2 cells, and control group was set up at the same time. The proliferation activities of cells were observed by MTT assay to confirm the optimum reversal concentration of PH. The FoxO1 mRNA and protein expression levels were detected by Real-time PCR and Western blotting methods. Results: The glucose consumption decreased by 45.84% in HepG2/IR after treated with 1 X 10-7 mol ~ L-1 insulin for 36 h, and there was significant difference compared with control group (P〈0.05), the proliferation activity of cells had no change in the HepG2/IR-PH after treated with 1.25 mmol · L^-1 PH for 24 h (P〉0.05). Compared with control group, the expression levels of FoxO1 mRNA and protein in HepG2/IR were significantly increased (P〈0.01), compared with control group, the expression levels of FoxO1 mRNA and protein in HepG2/IR-PH had no significant differences (P〉0.05). Conclusion: The IR of HepG2/IR is associated with the FoxO1 mRNA expression. The detection of FoxO1 mRNA seems to be an indicator to evaluate the efficacy of insulin sensitizer, and inhibiting the expression of FoxO1 mRNA may be develop
作者 孙静 魏虎来
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2017年第4期709-714,共6页 Journal of Jilin University:Medicine Edition
基金 中央高校基本科研业务费专项资金资助课题(861174) 甘肃省科技厅自然科学基金青年科研基金资助课题(1308RJYA065) 甘肃省卫计委卫生行业计划项目资助课题(GSWSKY-2015-64)
关键词 人源肝癌HepG2细胞 胰岛素抵抗 胰岛素抵抗逆转 叉头状转录因子O1基因 HepG2 cells, insulin resistance, insulin resistance reversal, forkhead transcription factor
  • 相关文献

参考文献4

  • 1王吉耀主编,丁小强等编写..内科学[M].上海:复旦大学出版社,2005:374.
  • 2陈秋..蜕皮甾酮的胰岛素增敏作用及其机制的实验研究[D].重庆医科大学,2005:
  • 3张正良,车向明,白郑海,王海,孙江利,赵伟,贺仕才,李海军.FOXA1和YAP在胃癌中的表达及临床意义[J].西安交通大学学报(医学版),2015,36(5):667-671. 被引量:9
  • 4金晶..吡格列酮对胰岛素抵抗血管内皮细胞保护机制的研究[D].吉林大学,2015:

二级参考文献16

  • 1JEMAL A, BRAY F, CENTER MM, et al. Global cancer sta- tisticsEJ~. CA Cancer J Clin, 2011, 61 (2) : 69-90. 被引量:1
  • 2KAESTNER KH. The FoxA factors in organogenesis and dif- ferentiationEJ]. Curr Opin Genet Dev, 2010, 20(5),527-632. 被引量:1
  • 3KATOH M, IGARASHI M, FUKUDA H, et al. Cancer ge- netics and genomics of human FOX family genesEJ]. Cancer Lett, 2013, 328(2):198-206. 被引量:1
  • 4MEHTA RJ, JAIN RK, LEUNG S, et al. FOXA1 is an inde- pendent prognostic marker for ER-positive breast cancerFJ]. Breast Cancer Res Treat, 2012, 131(3),881-890. 被引量:1
  • 5OVERHOLTZER M, ZHANG J, SMOLEN GA, et al. Trans- forming properties of YAP, a candidate oncogene on the chro- mosome 11q22 ampliconEJ]. Proc Natl Acad Sci U S A, 2006, 103(33) :12405-12410. 被引量:1
  • 6ZHANG C, WANG L, WU D, et al. Definition of a FoxA1 Cistrome that is crucial for G1 to S-phase cell-cycle transit in castration-resistant prostate cancer[-J]. Cancer Res, 2011, 71 (21) ~6738-6748. 被引量:1
  • 7YU W, QIAO Y, TANG X, et al. Tumor suppressor long non- coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA1 in liver cancer cells[-J]. Cell Signal, 2014, 26(12) :2961-2968. 被引量:1
  • 8TSCHAHARGANEH DF, CHEN X, LATZKO P, et al. Yes- associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinomal-J]. Gastroenterol- ogy, 2013, 144(7):1530-1542.e12. 被引量:1
  • 9JAIN RK, MEHTA RJ, NAKSHATRI H, et al. High-level ex- pression of forkhead-box protein A1 in metastatic prostate cancer[J]. Histopathology, 2011, 58(5),766-772. 被引量:1
  • 10NUCERA C, EECKHOUTE J, FINN S, et al. FOXA1 is a po- tential oncogene in anaplastic thyroid carcinomaFJ]. Clin Canc- er Res, 2009, 15(11) :3680-3689. 被引量:1

共引文献8

同被引文献20

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部